Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BR+MD Consultants is a professional education, training, and product distribution company specializing in intravenous and advanced delivery formulations of nicotinamide adenine dinucleotide (NAD+). Founded in 2014 by Dr. Richard F. Mestayer III and Paula Norris Mestayer, the company serves as the training and product branch of the BR+NAD® legacy, which also includes the Springfield Wellness Center and the nonprofit NAD Research, Inc. BR+MD Consultants certifies healthcare professionals in the administration of the proprietary BR+NAD® protocol, which is clinically utilized to support addiction recovery, mental health, neuroprotection, and overall brain restoration. Additionally, the company exclusively distributes advanced NAD+ products, including the nanoNAD+® Power Spray, MitOJet™ intranasal spray, and nanoNAD+® Ultimate Dermaceutical Cream.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BR+MD Consultants.